MemorialCare Heart & Vascular Institute at Long Beach Medical Center Emerges as the First Healthcare Facility!

MemorialCare Heart & Vascular Institute at Long Beach Medical Center Emerges as the First Healthcare Facility!

35mm Navitor Valve Implantation – A Minimally Invasive Option

Introduction

The MemorialCare Heart & Vascular Institute at Long Beach Medical Center has achieved a milestone by implanting a 35mm Abbott Titan Navitor Valve during a Transcatheter Aortic Valve Implantation (TAVI) procedure. This is a breakthrough for patients with severe aortic stenosis who are at extreme risk for open-heart surgery, offering a minimally invasive approach to treatment to improve the patient’s quality of life and reduce recovery time.

The Navitor valve – A new ray of hope

The Navitor valve is one of the newest valve replacement devices approved by the U. S. Food and Drug Administration for TAVI procedures. It is different from other valves on the market as it provides improved blood flow (hemodynamic) performance and ease of use. The Navitor TAVI system allows more patients, who would not be viable candidates for TAVI procedures, access to valve replacement treatment, giving hope to those previously considered untreatable.

Heart valve disease and its limitations

Heart valve disease is a condition in which the heart can’t pump blood through the body adequately, leading to various complications. It is a widely prevalent condition affecting millions of people worldwide. The Navitor TAVI system has been rigorously tested and proven to yield positive 30-day outcomes in patients with symptomatic severe aortic stenosis, including a 0% chance of moderate or severe paravalvular leak (PVL), 1.9% chance of all-cause mortality, 1.9% chance of disabling stroke, and 4.2% chance of major vascular complications, proving its remarkable safety and effectiveness in TAVR procedures.

The Navitor valve’s impact in treating valve disease

The Navitor TAVI system has been tested and shown to greatly improve the blood flow of patients with symptomatic severe aortic stenosis, helping their hearts resume normal, healthy blood flow performance quickly. This minimally invasive approach shortens hospital stays, reduces the risk of infection, and lessens recovery time providing improved care and quality of life to people that previously would have needed open-heart surgery for a solution.

Conclusion

MemorialCare Heart & Vascular Institute at Long Beach Medical Center is dedicated to offering state-of-the-art, personalized patient care to the community. The Navitor TAVI System offers a minimally invasive treatment option to patients who were at high risk, who had large native aortic valves and severe aortic stenosis valve disease, who may not have been able to receive treatment as previous TAVI valves were not large enough to accommodate their anatomy. The Navitor valve provides a new ray of hope for those previously untreatable, improving the quality of life, safety, and effectiveness of care for patients with heart valve disease.

Originally Post From https://www.prnewswire.com/news-releases/memorialcare-heart–vascular-institute-at-long-beach-medical-center-is-first-hospital-in-southern-california-to-perform-transcatheter-aortic-valve-implantation-with-navitor-titon-35mm-valve-302179286.html

Read more about this topic at
Aortic Valve Replacement: Minimally Invasive
Minimally invasive heart surgery

Improved Target Deficits and Quality of Life for HER2+ Breast Cancer with Tucatinib-Based Regimen

Tattoos Linked to Higher Risk of Blood Cancer in New Study